文献速递心外重症与机械循环支持

美国医院所有制对左心室辅助装置植入结局的影响

Effect of Hospital Ownership on Outcomes After Left Ventricular Assist Device Implantation in the United States.
PubMed 文献 · Ann Thorac Surg · 2018-10-11

该研究利用美国全国住院患者样本(2009-2014年)分析医院所有制(非联邦政府、非营利、营利)对连续流左心室辅助装置(LVAD)植入院内结局的影响。共纳入3,571例患者(加权17,547例),发现非营利医院院内死亡率逐年下降(年均变化-7.4%,p=0.001),营利医院死亡率更高;非联邦政府医院费用最高,非营利医院非 routine 出院更常见。不同所有制医院术后并发症无差异。

要点

  • 非营利医院LVAD院内死亡率年均下降7.4%(p=0.001),营利医院死亡率更高。
  • 非联邦政府医院费用最高($227,930),营利医院费用较低($148,406,p=0.03)。
  • 非营利医院非 routine 出院率73.6%,显著高于政府医院48.8%和营利医院59.8%(p<0.001)。

核心结论

  • 不同所有制医院在LVAD植入的院内死亡率、费用和出院去向方面存在差异。

研究设计与样本

  • 基于美国全国住院患者样本(National Inpatient Sample)的回顾性队列研究,纳入2009至2014年3,571例(加权17,547例)连续流LVAD植入患者。

主要发现

  • 非营利医院占82.1%,非联邦政府医院占15.6%,营利医院占2.3%。
  • 非营利医院院内死亡率年均变化-7.4%(p=0.001),营利医院死亡率高于其他所有制医院。
  • 术后并发症在不同所有制医院间无差异。
  • 非联邦政府医院费用最高($227,930;IQR $173,259-$301,566),营利医院费用较低($148,406;IQR $133,149-$199,317;p=0.03)。
  • 非营利医院非 routine 出院率73.6%(IQR 69.5%-77.7%),高于非联邦政府医院48.8%(IQR 42.4%-55.1%)和营利医院59.8%(IQR 43.0%-76.6%)(p<0.001)。

临床怎么用

  • 临床医生及医院管理者应关注医院所有制差异对LVAD植入结局、费用及出院去向的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We evaluated the effects of hospital ownership, classified into three tiers (nonfederal government, not-for-profit, and for-profit hospitals), on in-hospital outcomes after implantation of continuous-flow left ventricular assist devices (LVADs) in the United States from 2009 to 2014. METHODS: Data from the National Inpatient Sample were used to calculate annual national estimates in utilization, in-hospital mortality, major complications, lengths of stay, cost of hospitalization, and disposition at discharge for years 2009 to 2014. Complications were calculated using patient safety indicators and International Classification of Diseases, Ninth Revision, Clinical Modification codes. RESULTS: Of the 3,571 patients (weighted, 17,547) with LVAD implants in the United States between 2009 and 2014, 82.1% were in not-for-profit hospitals, 15.6% in nonfederal government hospitals, and 2.3% in for-profit hospitals. In-hospital mortality significantly decreased over time only in not-for-profit hospitals by average annual change of -7.4% (p = 0.001) and was higher in for-profit hospitals than other tiers of hospital ownership. Our analysis did not suggest any differences in postoperative complications among different hospital ownership types. LVAD implantation in nonfederal government hospitals was associated with the highest cost ($227,930; interquartile range [IQR], $173,259 to $301,566) and implantation in for-profit hospitals was associated with lower cost ($148,406; IQR, $133,149 to $199,317; p = 0.03). The length of stay was similar across the three tiers of hospital ownership. Nonroutine discharge was significantly more frequent in not-for-profit hospitals (73.6%; IQR 69.5% to 77.7%) compared with nonfederal government (48.8%; IQR, 42.4% to 55.1%) and for-profit (59.8%; IQR, 43.0% to 76.6%) hospitals (p < 0.001). CONCLUSIONS: Disparities in in-hospital mortality, cost, and disposition exist between various hospital ownerships during admission for LVAD implant.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Briasoulis A, Inampudi C, Akintoye E, et al. Effect of Hospital Ownership on Outcomes After Left Ventricular Assist Device Implantation in the United States. Ann Thorac Surg. 2018. PMID: 30316859. doi:10.1016/j.athoracsur.2018.08.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。